121 related articles for article (PubMed ID: 36946609)
1. Curcumin Enhances the Efficacy of Docetaxel by Promoting Anti-Tumor Immune Response in Head and Neck Squamous Cell Carcinoma.
Sun L; Yao X; Liu J; Zhang Y; Hu J
Cancer Invest; 2023 May; 41(5):524-533. PubMed ID: 36946609
[TBL] [Abstract][Full Text] [Related]
2. Macrophage secretory IL-1β promotes docetaxel resistance in head and neck squamous carcinoma via SOD2/CAT-ICAM1 signaling.
Hsieh CY; Lin CC; Huang YW; Chen JH; Tsou YA; Chang LC; Fan CC; Lin CY; Chang WC
JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36264639
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma.
Okuyama K; Naruse T; Yanamoto S
J Exp Clin Cancer Res; 2023 May; 42(1):114. PubMed ID: 37143088
[TBL] [Abstract][Full Text] [Related]
4. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer.
Liu L; Lim MA; Jung SN; Oh C; Won HR; Jin YL; Piao Y; Kim HJ; Chang JW; Koo BS
Phytomedicine; 2021 Nov; 92():153758. PubMed ID: 34592487
[TBL] [Abstract][Full Text] [Related]
5. Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms.
Zhao C; Zhou X; Cao Z; Ye L; Cao Y; Pan J
Phytomedicine; 2023 Oct; 119():154986. PubMed ID: 37506572
[TBL] [Abstract][Full Text] [Related]
6. TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells.
Mao L; Xiao Y; Yang QC; Yang SC; Yang LL; Sun ZJ
Oral Oncol; 2021 Oct; 121():105472. PubMed ID: 34333450
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.
Takahashi H; Sakakura K; Mito I; Ida S; Chikamatsu K
Cancer Sci; 2016 Aug; 107(8):1065-71. PubMed ID: 27228557
[TBL] [Abstract][Full Text] [Related]
8. Sunitinib attenuates reactive MDSCs enhancing anti-tumor immunity in HNSCC.
Liu J; Lin WP; Su W; Wu ZZ; Yang QC; Wang S; Sun TG; Huang CF; Wang XL; Sun ZJ
Int Immunopharmacol; 2023 Jun; 119():110243. PubMed ID: 37137265
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis promotes anti-tumor immune response by inducing immunogenic exposure in HNSCC.
Zhao YY; Lian JX; Lan Z; Zou KL; Wang WM; Yu GT
Oral Dis; 2023 Apr; 29(3):933-941. PubMed ID: 34773344
[TBL] [Abstract][Full Text] [Related]
10. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.
Weed DT; Vella JL; Reis IM; De la Fuente AC; Gomez C; Sargi Z; Nazarian R; Califano J; Borrello I; Serafini P
Clin Cancer Res; 2015 Jan; 21(1):39-48. PubMed ID: 25320361
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
Sivanantham B; Sethuraman S; Krishnan UM
ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
[TBL] [Abstract][Full Text] [Related]
12. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.
Espinosa-Cotton M; Rodman Iii SN; Ross KA; Jensen IJ; Sangodeyi-Miller K; McLaren AJ; Dahl RA; Gibson-Corley KN; Koch AT; Fu YX; Badovinac VP; Laux D; Narasimhan B; Simons AL
J Immunother Cancer; 2019 Mar; 7(1):79. PubMed ID: 30890189
[TBL] [Abstract][Full Text] [Related]
14. Metformin Effects on FOXP3
Amin D; Richa T; Mollaee M; Zhan T; Tassone P; Johnson J; Luginbuhl A; Cognetti D; Martinez-Outschoorn U; Stapp R; Solomides C; Rodeck U; Curry J
Laryngoscope; 2020 Sep; 130(9):E490-E498. PubMed ID: 31593308
[TBL] [Abstract][Full Text] [Related]
15. Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity.
Moreira D; Sampath S; Won H; White SV; Su YL; Alcantara M; Wang C; Lee P; Maghami E; Massarelli E; Kortylewski M
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33232304
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
Stoehr M; Mozet C; Boehm A; Aigner A; Dietz A; Wichmann G
Cancer Chemother Pharmacol; 2014 Apr; 73(4):827-37. PubMed ID: 24562588
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro effects of curcumin on head and neck carcinoma: a systematic review.
Borges GÁ; Rêgo DF; Assad DX; Coletta RD; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2017 Jan; 46(1):3-20. PubMed ID: 27219631
[TBL] [Abstract][Full Text] [Related]
19. Black raspberry extract inhibits regulatory T-cell activity in a murine model of head and neck squamous cell carcinoma chemoprevention.
Ryan NM; Lamenza FF; Upadhaya P; Pracha H; Springer A; Swingler M; Siddiqui A; Oghumu S
Front Immunol; 2022; 13():932742. PubMed ID: 36016924
[TBL] [Abstract][Full Text] [Related]
20. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.
Crist M; Yaniv B; Palackdharry S; Lehn MA; Medvedovic M; Stone T; Gulati S; Karivedu V; Borchers M; Fuhrman B; Crago A; Curry J; Martinez-Outschoorn U; Takiar V; Wise-Draper TM
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36328378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
